BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34475109)

  • 1. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
    Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
    Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
    Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
    Cuppens T; Moisse M; Depreeuw J; Annibali D; Colas E; Gil-Moreno A; Huvila J; Carpén O; Zikán M; Matias-Guiu X; Moerman P; Croce S; Lambrechts D; Amant F
    Int J Cancer; 2018 Mar; 142(6):1230-1243. PubMed ID: 29063609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Functional Role and Regulatory Mechanism of FTO m
    Yang Q; Al-Hendy A
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
    Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for BRCA1 in uterine leiomyosarcoma.
    Xing D; Scangas G; Nitta M; He L; Xu X; Ioffe YJ; Aspuria PJ; Hedvat CY; Anderson ML; Oliva E; Karlan BY; Mohapatra G; Orsulic S
    Cancer Res; 2009 Nov; 69(21):8231-5. PubMed ID: 19843854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Matrix Metalloproteinases 2 and 9 in Uterine Leiomyosarcoma.
    Wang X; Li C; Lou L; Zhu H
    Anticancer Res; 2024 Apr; 44(4):1465-1473. PubMed ID: 38537953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications.
    Dhingra S; Rodriguez ME; Shen Q; Duan X; Stanton ML; Chen L; Zhang R; Brown RE
    Int J Clin Exp Pathol; 2010 Jan; 4(2):134-46. PubMed ID: 21326806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor.
    Dorr C; Janik C; Weg M; Been RA; Bader J; Kang R; Ng B; Foran L; Landman SR; O'Sullivan MG; Steinbach M; Sarver AL; Silverstein KA; Largaespada DA; Starr TK
    Mol Cancer Res; 2015 Aug; 13(8):1238-47. PubMed ID: 25995385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.
    Kodama T; Newberg JY; Kodama M; Rangel R; Yoshihara K; Tien JC; Parsons PH; Wu H; Finegold MJ; Copeland NG; Jenkins NA
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3384-93. PubMed ID: 27247392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
    Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleeping Beauty transposon mutagenesis in mouse intestinal organoids identifies genes involved in tumor progression and metastasis.
    Iida N; Muranaka Y; Park JW; Sekine S; Copeland NG; Jenkins NA; Shiraishi Y; Oshima M; Takeda H
    Cancer Gene Ther; 2024 Apr; 31(4):527-536. PubMed ID: 38177308
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Tschida BR; Temiz NA; Kuka TP; Lee LA; Riordan JD; Tierrablanca CA; Hullsiek R; Wagner S; Hudson WA; Linden MA; Amin K; Beckmann PJ; Heuer RA; Sarver AL; Yang JD; Roberts LR; Nadeau JH; Dupuy AJ; Keng VW; Largaespada DA
    Cancer Res; 2017 Dec; 77(23):6576-6588. PubMed ID: 28993411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment.
    An Y; Wang S; Li S; Zhang L; Wang D; Wang H; Zhu S; Zhu W; Li Y; Chen W; Ji S; Guo X
    BMC Cancer; 2017 Sep; 17(1):639. PubMed ID: 28893210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
    Zhang P; Zhang H; Wang Y
    Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma.
    Brewer Savannah KJ; Demicco EG; Lusby K; Ghadimi MP; Belousov R; Young E; Zhang Y; Huang KL; Lazar AJ; Hunt KK; Pollock RE; Creighton CJ; Anderson ML; Lev D
    Clin Cancer Res; 2012 Sep; 18(17):4633-45. PubMed ID: 22821997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
    Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
    Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.
    Rangel R; Lee SC; Hon-Kim Ban K; Guzman-Rojas L; Mann MB; Newberg JY; Kodama T; McNoe LA; Selvanesan L; Ward JM; Rust AG; Chin KY; Black MA; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7749-E7758. PubMed ID: 27849608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionality of the Tumor Suppressor
    Stope MB; Cernat V; Kaul A; Diesing K; Koensgen D; Burchardt M; Mustea A
    Anticancer Res; 2018 Mar; 38(3):1547-1550. PubMed ID: 29491084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.